A device evaluation and/or device history review is anticipated, but is not complete.
Upon completion, a supplemental report will be filed.
(b)(4).
Suspect product name and strength: bupivacaine hcl (0.
75%) with dextrose (8.
25%), 2 ml (marcaine).
Pma/510k number: enforcement discretion.
|
It was reported that tray spn spt24g3.
5 l/b-d/e failed to work.
The following information was provided by the initial reporter: "it was reported that the marcaine in the spinal tray is compromised.
Event description per attached email states: there is concern that these lots have issues with the marcaine that is supplied in the trays.
There have been a few reports.
Pt scheduled for c/section this am was positioned for a spinal in or.
Dr.
Administered spinal anesthesia without difficulty, was confident in placement.
Patient did not receive adequate anesthesia to proceed with c/section, case was converted to general anesthesia and proceeded without incident.
Dr.
Was concerned that this is the second such case in 36 hours.
He had the same incident on a patient on 6/14 at 2100.
Again, dr.
Was confident the placement was appropriate, but patient did not receive adequate anesthesia for the procedure and required general anesthesia.
Dr.
Is concerned that the marcaine in the spinal trays is compromised.
".
|